PDAC subtypes Tumor microenvironment and combinatorial therapy strategy

I finished my undergrad in Biotechnology at Atma Jaya University, Indonesia (2017). Then I continued with my master’s degree in cell biology at TU Kaiserslautern, Germany (2021), where I analyzed the phenotypic consequences of polyploidy, which is a hallmark of cancer. In 2022 I joined the AG Saur group as Ph.D. researcher. I mainly work on defining the subtype-specific inflammatory drivers in PDAC and investigate its combinatorial therapy using a mouse model.